414 related articles for article (PubMed ID: 34050913)
41. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP
J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818
[TBL] [Abstract][Full Text] [Related]
42. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
Wu MA; Zanichelli A; Mansi M; Cicardi M
Expert Opin Pharmacother; 2016; 17(1):27-40. PubMed ID: 26512744
[TBL] [Abstract][Full Text] [Related]
43. Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema.
Bindke G; Gehring M; Wieczorek D; Kapp A; Buhl T; Wedi B
Allergy; 2022 Mar; 77(3):946-955. PubMed ID: 34287950
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
[TBL] [Abstract][Full Text] [Related]
45. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations.
Bork K; Wulff K; Witzke G; Hardt J
Allergy; 2015 Aug; 70(8):1004-12. PubMed ID: 25952149
[TBL] [Abstract][Full Text] [Related]
46. Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.
Nebenführer Z; Szabó E; Kajdácsi E; Kőhalmi KV; Karádi I; Zsáry A; Farkas H; Cervenak L
Ann Allergy Asthma Immunol; 2019 Jan; 122(1):86-92. PubMed ID: 30312677
[TBL] [Abstract][Full Text] [Related]
47. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
Magerl M; Germenis AE; Maas C; Maurer M
Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
[TBL] [Abstract][Full Text] [Related]
48. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.
Andrási N; Veszeli N; Kőhalmi KV; Csuka D; Temesszentandrási G; Varga L; Farkas H
J Allergy Clin Immunol Pract; 2018; 6(4):1205-1208. PubMed ID: 29715562
[TBL] [Abstract][Full Text] [Related]
49. Hereditary Angioedema.
Wilkerson RG; Moellman JJ
Immunol Allergy Clin North Am; 2023 Aug; 43(3):533-552. PubMed ID: 37394258
[TBL] [Abstract][Full Text] [Related]
50. [Management of angioedema. Guidelines of the Angiology Section of Slovak Medical Chamber (2013)].
Gavorník P; Gašpar Ľ; Dukát A
Vnitr Lek; 2014; 60(5-6):490-8. PubMed ID: 24974754
[TBL] [Abstract][Full Text] [Related]
51. Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization.
Christiansen SC; Zuraw BL
Immunol Allergy Clin North Am; 2024 Aug; 44(3):543-560. PubMed ID: 38937015
[TBL] [Abstract][Full Text] [Related]
52. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
53. [Hereditary angioedema biological diagnosis].
Ponard D
Presse Med; 2015 Jan; 44(1):57-64. PubMed ID: 25511654
[TBL] [Abstract][Full Text] [Related]
54. Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency.
Kajdácsi E; Veszeli N; Mező B; Jandrasics Z; Kőhalmi KV; Ferrara AL; Cervenak L; Varga L; Farkas H
Clin Rev Allergy Immunol; 2021 Jun; 60(3):383-395. PubMed ID: 33606193
[TBL] [Abstract][Full Text] [Related]
55. A first of its kind quantitative functional C1-esterase inhibitor lateral flow assay for hereditary angioedema point-of-care diagnostic testing.
Chockalingam PS; Zhou Z; Garg BK; Boehringer H; Chung R; Fait S
Int Immunopharmacol; 2020 Jun; 83():106526. PubMed ID: 32361670
[TBL] [Abstract][Full Text] [Related]
56. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
Riedl M
Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
[TBL] [Abstract][Full Text] [Related]
57. Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema.
Qiu T; Chiuchiolo MJ; Whaley AS; Russo AR; Sondhi D; Kaminsky SM; Crystal RG; Pagovich OE
Allergy; 2019 Jun; 74(6):1081-1089. PubMed ID: 30059156
[TBL] [Abstract][Full Text] [Related]
58. Health-related quality of life among children with hereditary angioedema.
Engel-Yeger B; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Kessel A
Pediatr Allergy Immunol; 2017 Jun; 28(4):370-376. PubMed ID: 28258590
[TBL] [Abstract][Full Text] [Related]
59. Hereditary Angioedema Due to C1-Inhibitor Deficiency in Romania: First National Study, Diagnostic and Treatment Challenges.
Gabos G; Nadasan V; Mihaly E; Dobru D
Iran J Immunol; 2020 Sep; 17(3):226-235. PubMed ID: 32996899
[TBL] [Abstract][Full Text] [Related]
60. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
